Gemcitabine Injection
Hikma is recalling Gemcitabine Injection due to improper temperature storage.
Contact your healthcare provider or pharmacy if you have concerns about this medication. Do not use the affected product.
Why it was recalled
Hikma is recalling Gemcitabine Injection due to temperature abuse. The product was stored in a controlled room temperature environment instead of the required refrigerated conditions.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hikma, Berkeley Heights, NJ 07922. NDC: 0143-9341-01
- Recall #
- D-0714-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from McKesson
Editorial summary by Recall Canary · last updated 2026-07-22 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification